Lamers, M. M. & Haagmans, B. L. SARS-CoV-2 pathogenesis. Nat. Rev. Microbiol. 20, 270–284 (2022).
Agarwal, A. et al. A living WHO guideline on drugs for COVID-19. BMJ 370, m3379 (2020).
Yageta, Y. et al. Role of Nrf2 in host defense against influenza virus in cigarette smoke-exposed mice. J. Virol. 85, 4679–4690 (2011).
Kesic, M. J., Simmons, S. O., Bauer, R. & Jaspers, I. Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells. Free Radic. Biol. Med. 51, 444–453 (2011).
Waqas, F. H. et al. NRF2 activators inhibit influenza A virus replication by interfering with nucleo-cytoplasmic export of viral RNPs in an NRF2-independent manner. PLoS Pathog. 19, e1011506 (2023).
Olagnier, D. et al. SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate. Nat. Commun. 11, 4938 (2020).
Sohail, A. et al. Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection. PLoS Pathog. 18, e1010219 (2022).
Chen, F. et al. Citraconate inhibits ACOD1 (IRG1) catalysis, reduces interferon responses and oxidative stress, and modulates inflammation and cell metabolism. Nat. Metab. 4, 534–546 (2022).
Kashyap, T. et al. Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo. Antivir. Res. 192, 105115 (2021).
Sharma, T. et al. Identifying novel inhibitors targeting exportin-1 for the potential treatment of COVID-19. Arch. Microbiol. 206, 69 (2024).
Li, W. et al. 4-octyl itaconate as a metabolite derivative inhibits inflammation via alkylation of STING. Cell Rep. 42, 112145 (2023).
Olagnier, D. et al. Nrf2 negatively regulates STING, indicating a link between antiviral sensing and metabolic reprogramming. Nat. Commun. 9, 3506 (2018).
Su, C., Cheng, T., Huang, J., Zhang, T. & Yin, H. 4-Octyl itaconate restricts STING activation by blocking its palmitoylation. Cell Rep. 42, 113040 (2023).
Wang, A. Y. & Liu, H. The past, present, and future of CRM1/XPO1 inhibitors. Stem Cell Investig. 6, 6 (2019).
Ribo-Molina, P. et al. 4-Octyl itaconate reduces influenza A replication by targeting the nuclear export protein CRM1. J. Virol. 97, e0132523 (2023).
Kurmasheva, N. et al. Octyl itaconate enhances VSVDelta51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways. Nat. Commun. 15, 4096 (2024).
Shen, H. et al. MDM2-mediated ubiquitination of angiotensin-converting enzyme 2 contributes to the development of pulmonary arterial hypertension. Circulation 142, 1190–1204 (2020).
Shu, Z. et al. MG-132 activates sodium palmitate-induced autophagy in human vascular smooth muscle cells and inhibits senescence via the PI3K/AKT/mTOR axis. Lipids Health Dis. 23, 282 (2024).
Liu, Z. et al. METTL14-mediated m6A modification of ZFP14 inhibits clear cell renal cell carcinoma progression via promoting STAT3 ubiquitination. Clin. Transl. Med. 15, e70232 (2025).
Fu, S. C., Huang, H. C., Horton, P. & Juan, H. F. ValidNESs: a database of validated leucine-rich nuclear export signals. Nucleic Acids Res. 41, D338–D343 (2013).
Lang, R. & Siddique, M. Control of immune cell signaling by the immuno-metabolite itaconate. Front. Immunol. 15, 1352165 (2024).
McGettrick, A. F., Bourner, L. A., Dorsey, F. C. & O’Neill, L. A. J. Metabolic Messengers: itaconate. Nat. Metab. 6, 1661–1667 (2024).
Hill, C. R. et al. Characterisation of the roles of ABCB1, ABCC1, ABCC2 and ABCG2 in the transport and pharmacokinetics of actinomycin D in vitro and in vivo. Biochem. Pharm. 85, 29–37 (2013).
Cabirac, G. F. et al. In vitro interaction of coronaviruses with primate and human brain microvascular endothelial cells. Adv. Exp. Med. Biol. 380, 79–88 (1995).
Everest, H., Stevenson-Leggett, P., Bailey, D., Bickerton, E. & Keep, S. Known cellular and receptor interactions of animal and human coronaviruses: a review. Viruses 14 https://doi.org/10.3390/v14020351 (2022).
Espinoza, J. A., Gonzalez, P. A. & Kalergis, A. M. Modulation of antiviral immunity by heme oxygenase-1. Am. J. Pathol. 187, 487–493 (2017).
Suzuki, H. et al. Heme regulates gene expression by triggering Crm1-dependent nuclear export of Bach1. EMBO J. 23, 2544–2553 (2004).
Liu, Y. et al. Comparative transcriptome analysis of SARS-CoV-2, SARS-CoV, MERS-CoV, and HCoV-229E identifying potential IFN/ISGs targets for inhibiting virus replication. Front. Med. 10, 1267903 (2023).
Petersen, H. et al. NS segment of a 1918 influenza A virus-descendent enhances replication of H1N1pdm09 and virus-induced cellular immune response in mammalian and avian systems. Front. Microbiol. 9, 526 (2018).
Wang, C. W., Chuang, H. C. & Tan, T. H. ACE2 in chronic disease and COVID-19: gene regulation and post-translational modification. J. Biomed. Sci. 30, 71 (2023).
Wang, R. et al. Ubiquitination of angiotensin-converting enzyme 2 contributes to the development of pulmonary arterial hypertension mediated by neural precursor cell-expressed developmentally down-regulated gene 4-Like. Respir. Res. 25, 326 (2024).
Emslander, Q. et al. MDM2 influences ACE2 stability and SARS-CoV-2 uptake. Viruses 15 https://doi.org/10.3390/v15081763 (2023).
Bourner, L. A. et al. Endogenously produced itaconate negatively regulates innate-driven cytokine production and drives global ubiquitination in human macrophages. Cell Rep. 43, 114570 (2024).
Schuster, E. M. et al. TFEB induces mitochondrial itaconate synthesis to suppress bacterial growth in macrophages. Nat. Metab. 4, 856–866 (2022).
Pan, X. et al. Four-octyl itaconate improves osteoarthritis by enhancing autophagy in chondrocytes via PI3K/AKT/mTOR signalling pathway inhibition. Commun. Biol. 5, 641 (2022).
Kwanten, B. et al. E3 ubiquitin ligase ASB8 promotes selinexor-induced proteasomal degradation of XPO1. Biomed. Pharmacother. 160, 114305 (2023).
Breit, M. N. et al. Biologic activity of the novel orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 against canine melanoma cell lines. BMC Vet. Res. 10, 160 (2014).
Tai, Y. T. et al. CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications. Leukemia 28, 155–165 (2014).
Wing, C. E. et al. SINE compounds activate exportin 1 degradation through an allosteric mechanism. Nat. Chem. Biol. 21, 2002–2013 (2025).
Chen, L. L. et al. Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses. Nat. Cell Biol. 24, 353–363 (2022).
Wen, T. et al. KPT-330 and Y219 exert a synergistic antitumor effect in triple-negative breast cancer through inhibiting NF-kappaB signaling. FEBS Open Bio 13, 751–762 (2023).
Ibanez, F. J. et al. Pharmacological induction of heme oxygenase-1 impairs nuclear accumulation of herpes simplex virus capsids upon infection. Front. Microbiol. 8, 2108 (2017).
Lee, J. G. et al. Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor. Cell Biosci. 11, 58 (2021).
Feng, S., O’Brien, A., Chen, D. Y., Saeed, M. & Baker, S. C. SARS-CoV-2 nonstructural protein 6 from Alpha to Omicron: evolution of a transmembrane protein. mBio 14, e0068823 (2023).
Sun, Q. et al. Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease. Signal. Transduct. Target Ther. 6, 212 (2021).
Wang, X. Y. et al. Bardoxolone methyl (CDDO-Me or RTA402) induces cell cycle arrest, apoptosis and autophagy via PI3K/Akt/mTOR and p38 MAPK/Erk1/2 signaling pathways in K562 cells. Am. J. Transl. Res. 9, 4652–4672 (2017).
Lekshmi, V. S. et al. PI3K/Akt/Nrf2 mediated cellular signaling and virus-host interactions: latest updates on the potential therapeutic management of SARS-CoV-2 infection. Front. Mol. Biosci. 10, 1158133 (2023).
Bouhaddou, M. et al. The global phosphorylation landscape of SARS-CoV-2 infection. Cell 182, 685–712 e619 (2020).
Dey, S. & Mondal, A. Unveiling the role of host kinases at different steps of influenza A virus life cycle. J. Virol. 98, e0119223 (2024).
Kashyap, T. et al. Selinexor reduces the expression of DNA damage repair proteins and sensitizes cancer cells to DNA damaging agents. Oncotarget 9, 30773–30786 (2018).
Casares, L. et al. The synthetic triterpenoids CDDO-TFEA and CDDO-Me, but not CDDO, promote nuclear exclusion of BACH1 impairing its activity. Redox Biol. 51, 102291 (2022).
Kyung, S. Y. et al. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition. BMC Pharm. Toxicol. 19, 13 (2018).
Torrente, L. et al. Crosstalk between NRF2 and HIPK2 shapes cytoprotective responses. Oncogene 36, 6204–6212 (2017).
Merkert, S. et al. Generation of two human NRF2 knockout iPSC clones using CRISPR/Cas9 editing. Stem Cell Res 69, 103090 (2023).
Olmer, R. et al. Differentiation of human pluripotent stem cells into functional endothelial cells in scalable suspension culture. Stem Cell Rep. 10, 1657–1672 (2018).
Carter-Timofte, M. E. et al. Antiviral potential of the antimicrobial drug atovaquone against SARS-CoV-2 and emerging variants of concern. ACS Infect. Dis. 7, 3034–3051 (2021).
Pfefferle, S. et al. The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors. PLoS Pathog. 7, e1002331 (2011).
Zapatero-Belinchon, F. J. et al. Fluvastatin mitigates SARS-CoV-2 infection in human lung cells. iScience 24, 103469 (2021).
Corman, V. M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro. Surveill. 25 https://doi.org/10.2807/1560-7917.ES.2020.25.3.2000045 (2020).
Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271–280 e278 (2020).
Berger Rentsch, M. & Zimmer, G. A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon. PLoS ONE 6, e25858 (2011).
Waqas, S. F. et al. ISG15 deficiency features a complex cellular phenotype that responds to treatment with itaconate and derivatives. Clin. Transl. Med. 12, e931 (2022).
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
Liao, Y., Smyth, G. K. & Shi, W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res. 47, e47 (2019).
Robinson, M. D. & Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 11, R25 (2010).
Pang, Z. et al. Using MetaboAnalyst 5.0 for LC-HRMS spectra processing, multi-omics integration and covariate adjustment of global metabolomics data. Nat. Protoc. 17, 1735–1761 (2022).